Nvidia's Nebius Stake and Pharma AI Factory Offer Fresh Growth Angles as Stock Stays Rangebound

Nvidia discloses 9.3% passive stake in Nebius, Q1 revenue surges 85% to $81.6B, but stock remains range-bound amid power consumption concerns.

Nvidia has quietly deepened its ties to the cloud infrastructure space, disclosing a 9.3 percent stake in Nebius Group in a July 20 SEC filing. The holding, flagged as a passive investment, comprises 22.3 million shares — nearly all of them tied to warrants from a $2 billion injection into Nebius back in March. The warrants cannot be exercised until September 11, 2026, and the underlying shares cannot be sold before that date either. The move locks in a partner that will deploy Nvidia chips at scale, extending a pattern of equity-backed customer relationships.

The Nebius news bolstered a stock already benefiting from a newly secured $775 million credit facility backed by GPU capacity and a data-center deal with Reflection AI worth over $1 billion. Nebius shares shot up nearly 4 percent in after-hours trading, and analysts responded quickly: Northland raised its target to $410 from $248, while Freedom Capital upgraded the stock to Buy with a $200 price target.

Even as Nvidia makes these tactical bets, its core business continues to fire on all cylinders. First-quarter revenue for fiscal 2027 hit $81.61 billion, up 85.2 percent year over year and well above the $78.42 billion consensus. Earnings per share of $1.87 also beat the $1.76 Street estimate. The data-center segment, now the company's engine room, surged 92 percent to $75.25 billion. For the current quarter, management guided for $91 billion in revenue. The board authorized an additional $80 billion in share repurchases and bumped the quarterly dividend to $0.25.

Yet the stock has been stuck in a narrow range since November, oscillating mostly between $205 and $212. At Tuesday's pre-market in Frankfurt, the shares were quoted at €179.02, a gain of 0.52 percent from Monday's close but still 11.6 percent below the €202.50 52-week high set in mid-May. The forward price-to-earnings ratio has compressed to roughly 22, a sharp comedown from prior valuations — even as earnings accelerate.

That disconnect has drawn skepticism from corners of the market. Investor David Desjardins slapped a Strong Sell rating on the stock, warning that growth faces physical limits. At a market capitalization near $5 trillion, Nvidia now represents about 7 percent of the S&P 500. He points to U.S. data-center power consumption projected by Goldman Sachs to climb from 31 gigawatts in 2025 to 66 gigawatts in 2027, consuming 8.5 percent of peak electricity load — a bottleneck he argues could throttle Nvidia's expansion. Meanwhile, Apple has retaken the crown as the world's most valuable company, with a market cap of $4.88 trillion versus Nvidia's $4.86 trillion, amid a broader semiconductor rout that has pushed the Philadelphia Semiconductor Index more than 20 percent below its June peak, formally into bear-market territory.

On the product front, CEO Jensen Huang pushed back against reports of delays for the upcoming Vera-Rubin platform, insisting production is running in "gigantic" volumes. The denial followed a report from SemiAnalysis claiming substantial setbacks, including a more-than-12-month delay for the Kyber-NVL144 system and the cancellation of the NVL72x2 model. KeyBanc, citing Huang's comments, raised its CoWoS forecast for 2027 to 1.1 million interposers, reinforcing confidence in the supply chain.

Adding to the growth narrative, Nvidia launched new open-source Omniverse libraries for physical-AI development, including modules for sensor simulation and GPU-accelerated physics. Partners such as SideFX, PTC, and ForgeCAD are on board, and RTX Spark systems are slated for fall 2026. More tangibly, Bristol Myers Squibb acquired a DGX SuperPOD built on the Vera-Rubin architecture to speed drug discovery. Nvidia says AI tools already cut development timelines by 20 to 30 percent, with potential to reach 50 percent, while the new platform delivers ten times the performance per watt of its predecessors.

Wall Street remains broadly bullish: 36 buy calls versus a single hold rating, with an average price target of $309.94. Morgan Stanley named Nvidia alongside Broadcom as top picks in AI compute after the sector pullback. Mizuho and JPMorgan argue that demand for AI infrastructure will stay robust into 2028 and beyond. Goldman Sachs noted that hedge funds have been unloading tech positions at the fastest pace on record since June, suggesting the recent slide owes more to technical repositioning than fundamental doubts.

For now, the stock sits about 2 percent below its 50-day moving average and roughly 8 percent above the 200-day line — a technical picture that mirrors the ambivalence of the fundamental one: record operating performance coexisting with a sideways price, heightened competition from hyperscaler custom chips, and zero revenue from China after $4.6 billion a year ago. The Nebius stake and pharma AI deals offer fresh angles, but the stock remains hostage to the tug-of-war between earnings momentum and macro headwinds.